The major factors for the growth of the novel drug delivery systems (NDDS) market include the growing need of controlled release of drugs, advancement in pharmacology promoting increased adoption of novel drug delivery systems (NDDS), and technological advancements promoting the development of NDDS. There has been a remarkable increase...
The North America wearable injectors Market is projected to reach US$ 5767.51 million by 2027 from US$ 2370.52 million in 2019. The market is estimated to grow at CAGR of 11.9% from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...
The Asia Pacific Wearable Injectors market is expected to reach US$ 2939.97 million by 2027 from US$ 1160.40 million in 2019. The market is estimated to grow at CAGR of 12.4% from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...
The Europe wearable injectors market is expected to reach US$ 3586.82 million in 2027 from US$ 1539.88 million in 2019. The market is estimated to grow with a CAGR of 11.3 % from 2020 to 2027. The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development,...
The liposome drug delivery market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow at a CAGR of 8.8% from 2020 to 2027. The growth of the market is attributed to a few key driving factors such as increasing prevalence of chronic diseases, growing demand for noninvasive...
The bioresorbable medical material was valued at US$ 935.99 million in 2019 and is expected to grow at a CAGR of 9.7% from 2020 to 2027 to reach US$ 1,942.13 million by 2027. Driving factors of the bioresorbable medical material market are rising adoption of bioresorbable polymers for medical use and increasing number of orthopedic...
The electronic drug delivery systems market is projected to grow at a CAGR of 8.7% during the forecast period (2019–2024). The electronic drug delivery systems market is projected to reach USD 11.9 billion by 2024 from USD 7.8 billion in 2019, at a CAGR of 8.7%. The growth of the electronic drug delivery systems market...
Drug delivery market in North America is expected to grow from US$ 572,452.95 Mn in the year 2018 and is expected to reach US$1,074,679.66 Mn by 2027 growing at a CAGR of 7.4% over the forecast period. Driving factors such as a rising number of patients suffering from chronic diseases and increasing adoption of non-invasive drug delivery...
The Europe drug delivery systems market is expected to reach US$ 610,320.4 Mn in 2027 from US$ 343,533.9 in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027. Factors such as rising investments by pharmaceutical companies and medical device companies in research and development and rise of chronic disease conditions...
Market Overview Global Smart Pills Drug Delivery market is expected to witness a CAGR of 11.50% during the forecast period. Certain factors that are driving the market growth include increasing preference for minimally invasive devices, increasing incidence of gastrointestinal disorders, and technological advancements. There...